Literature DB >> 3170713

Comparison of BACTEC 13A medium and Du Pont isolator for detection of mycobacteremia.

F G Witebsky1, J F Keiser, P S Conville, R Bryan, C H Park, R Walker, S H Siddiqi.   

Abstract

BACTEC 13A medium (Johnston Laboratories, Towson, Md.) was compared with Isolator (Du Pont Co., Wilmington, Del.) concentrate for sensitivity, speed, and technical ease of isolation of mycobacteria from paired patient blood samples. Of 72 positive cultures, 63 were positive by both systems. Five positive cultures were detected by BACTEC 13A medium alone, and four were detected by Isolator alone. The median numbers of days to positivity were 12 for BACTEC 13A medium and 14 for Isolator concentrate. BACTEC 13A medium has an advantage over the Isolator in requiring less laboratory manipulation of the specimen but has the disadvantages of not providing isolated colonies or quantitation of organisms. Some technical problems with contamination in both systems are also discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3170713      PMCID: PMC266650          DOI: 10.1128/jcm.26.8.1501-1505.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Laboratory diagnosis of mycobacterial infections in patients with acquired immunodeficiency syndrome.

Authors:  T E Kiehn; R Cammarata
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

2.  Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.

Authors:  H Masur; C Tuazon; V Gill; G Grimes; B Baird; A S Fauci; H C Lane
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

3.  Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndrome.

Authors:  P L Rogers; R E Walker; H C Lane; F G Witebsky; J A Kovacs; J E Parrillo; H Masur
Journal:  Am J Med       Date:  1988-03       Impact factor: 4.965

4.  Mycobacteremia and the new blood culture systems.

Authors:  P F Pierce; D R DeYoung; G D Roberts
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

5.  Mycobacterium simiae and Mycobacterium avium-M. intracellulare mixed infection in acquired immune deficiency syndrome.

Authors:  V Lévy-Frébault; B Pangon; A Buré; C Katlama; C Marche; H L David
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

6.  Use of lysis-centrifugation (isolator) and radiometric (BACTEC) blood culture systems for the detection of mycobacteremia.

Authors:  V J Gill; C H Park; F Stock; L L Gosey; F G Witebsky; H Masur
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

Review 7.  Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex.

Authors:  L S Young; C B Inderlied; O G Berlin; M S Gottlieb
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

8.  Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome.

Authors:  A M Macher; J A Kovacs; V Gill; G D Roberts; J Ames; C H Park; S Straus; H C Lane; J E Parrillo; A S Fauci
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

  8 in total
  12 in total

Review 1.  Update on detection of bacteremia and fungemia.

Authors:  L G Reimer; M L Wilson; M P Weinstein
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Rapid diagnosis of Mycobacterium tuberculosis bacteremia by PCR.

Authors:  L Folgueira; R Delgado; E Palenque; J M Aguado; A R Noriega
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Investigation of a pseudo-outbreak of Nocardia asteroides infection by pulsed-field gel electrophoresis and randomly amplified polymorphic DNA PCR.

Authors:  L Louie; M Louie; A E Simor
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Evaluation of the ESP Culture System II for recovery of mycobacteria from blood specimens collected in isolator tubes.

Authors:  C A Tholcken; S Huang; G L Woods
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

5.  Number of days required for recovery of mycobacteria from blood and other samples.

Authors:  J Esteban; A Molleja; R Fernández-Roblas; F Soriano
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

6.  Recovery of mycobacteria from blood in mycobacteria growth indicator tube and Lowenstein-Jensen slant after lysis-centrifugation.

Authors:  B A Hanna; S B Walters; S J Bonk; L J Tick
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

Review 7.  Bacteremia and fungemia in the immunocompromised patient.

Authors:  T E Kiehn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

8.  Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures.

Authors:  P M Small; N B McClenny; S P Singh; G K Schoolnik; L S Tompkins; P A Mickelsen
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

Review 9.  The new diagnostic mycobacteriology laboratory.

Authors:  M Salfinger; G E Pfyffer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

10.  Mediastinal mass mimicking a tumor in a patient with bladder cancer after Bacillus Calmette-Guerin treatment.

Authors:  A Somoskovi; C Carlyn; J Dormandy; M Salfinger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.